Loading clinical trials...
Loading clinical trials...
Combined Anabolic Therapy Study
Conditions
Interventions
Romosozumab
Teriparatide
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
February 3, 2025
Primary Completion Date
December 30, 2027
Completion Date
April 1, 2028
Last Updated
April 17, 2026
NCT06449742
NCT07474571
NCT06541548
NCT07254429
NCT04787679
NCT06731608
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions